Results for ptose translation from Danish to English

diplopi, ptose
diplopia, ptosis

johnson's ptose-tang
johnson instruments

ptose, tørre øjne konjunktivit
ptosis, dry eyes conjunctivitis

hængende øjenlåg (ptose), tørre øjne
drooping eyelid (ptosis), dry eyes

Øjne: maculaødem, konjunktivitis, øjenlågs-ptose, hornhindelidelse
eye disorders: macular oedema, conjunctivitis, eyelid ptosis, corneal disorder

maculaødem, iritis, konjunktivitis, øjenlågs- ptose, hornhindelidelse
macular oedema, iritis, conjunctivitis, eyelid ptosis, corneal disorder

ikke almindelige:hængende øjenlåg (ptose) , tørre øjne
drooping eyelid (ptosis) , dry eyes

for at reducere forekomsten af ptose må injektionerne helst ikke gives nær musculus levator palpebrae superioris.
injections near the levator palpebrae superioris should be avoided to reduce the occurrence of ptosis.

den hyppigst indberettede bivirkning var ptose (xeomin 6, 1%; botox 4, 6%).
the most frequently reported adverse event was ptosis (xeomin 6.1%; botox 4.6%).

den toksikologiske profil er pricipielt bestemt af lægemidlets farmakologiske profil: adfærdsændringer, hypoprolactæmi, fald i blodtryk og hjertefrekvens, ptose og spytafsondring.
the toxicology profile is principally determined by the pharmacological activity of the drug: behavioural changes, hypoprolactinaemia, decrease in blood pressure and heart rate, ptosis and salivation.

følgende virkninger er også blevet indberettet under brugen efter markedsføringen: unormal tilpasning, ptose, opkastning, obstipation, influenzalignende symptomer og asteni.
the following effects have also been reported during post marketing use: abnormal accommodation, ptosis, vomiting, constipation, flu-like symptoms, and asthenia.

det er rapporteret, at betablokkere potenserer muskelsvaghed svarende til visse myasteniske symptomer (f.eks. diplopi, ptose og generel svækkelse).
beta-adrenergic blocking medicinal products have been reported to potentiate muscle weakness consistent with certain myasthenic symptoms (eg, diplopia, ptosis and generalised weakness).

alle bivirkninger var af let til moderat grad bortset fra ét tilfælde af behandlingsrelateret ptose i xeomin - gruppen og ét tilfælde af ikke- behandlingsrelateret myokardieinfarkt i botox- gruppen.
all adverse events were of mild or moderate severity except one case of treatment-related ptosis in the xeomin and one case of unrelated myocardial infarction in the botox group.

symptomerne på overdosering opstår ikke umiddelbart efter injektionen, men kan omfatte generel svækkelse, ptose, diplopi, synke - og talebesvær eller lammelse af åndedrætsmusklerne, der fører til aspirationspneumoni.
symptoms of overdose are not immediately apparent post-injection and may include general weakness, ptosis, diplopia, swallowing and speech difficulties or paralysis of the respiratory muscles resulting in an aspiration pneumonia.

de hyppigste bivirkninger (dvs. med en forekomst 1%) var dysfagi, ptose, ryg -og knoglesmerter samt muskelsvaghed.størstedelen blev bedømt som lette eller moderate.
the most common aes (i. e. with an incidence of 1%) were dysphagia, ptosis, back and skeletal pain and muscle weakness, the majority of them assessed as mild or moderate.